128 related articles for article (PubMed ID: 24529902)
1. Preferential accumulation of the near infrared heptamethine dye IR-780 in the mitochondria of drug-resistant lung cancer cells.
Wang Y; Liu T; Zhang E; Luo S; Tan X; Shi C
Biomaterials; 2014 Apr; 35(13):4116-24. PubMed ID: 24529902
[TBL] [Abstract][Full Text] [Related]
2. A multifunctional heptamethine near-infrared dye for cancer theranosis.
Luo S; Tan X; Qi Q; Guo Q; Ran X; Zhang L; Zhang E; Liang Y; Weng L; Zheng H; Cheng T; Su Y; Shi C
Biomaterials; 2013 Mar; 34(9):2244-51. PubMed ID: 23261220
[TBL] [Abstract][Full Text] [Related]
3. A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging.
Zhang C; Liu T; Su Y; Luo S; Zhu Y; Tan X; Fan S; Zhang L; Zhou Y; Cheng T; Shi C
Biomaterials; 2010 Sep; 31(25):6612-7. PubMed ID: 20542559
[TBL] [Abstract][Full Text] [Related]
4. A NIR heptamethine dye with intrinsic cancer targeting, imaging and photosensitizing properties.
Tan X; Luo S; Wang D; Su Y; Cheng T; Shi C
Biomaterials; 2012 Mar; 33(7):2230-9. PubMed ID: 22182749
[TBL] [Abstract][Full Text] [Related]
5. The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer.
Zhou J; Zhao WY; Ma X; Ju RJ; Li XY; Li N; Sun MG; Shi JF; Zhang CX; Lu WL
Biomaterials; 2013 May; 34(14):3626-38. PubMed ID: 23422592
[TBL] [Abstract][Full Text] [Related]
6. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways.
Li N; Zhang CX; Wang XX; Zhang L; Ma X; Zhou J; Ju RJ; Li XY; Zhao WY; Lu WL
Biomaterials; 2013 Apr; 34(13):3366-80. PubMed ID: 23410681
[TBL] [Abstract][Full Text] [Related]
7. The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells.
Wang XX; Li YB; Yao HJ; Ju RJ; Zhang Y; Li RJ; Yu Y; Zhang L; Lu WL
Biomaterials; 2011 Aug; 32(24):5673-87. PubMed ID: 21550109
[TBL] [Abstract][Full Text] [Related]
8. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
9. IR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapy.
Yue C; Liu P; Zheng M; Zhao P; Wang Y; Ma Y; Cai L
Biomaterials; 2013 Sep; 34(28):6853-61. PubMed ID: 23777910
[TBL] [Abstract][Full Text] [Related]
10. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models.
Peer D; Dekel Y; Melikhov D; Margalit R
Cancer Res; 2004 Oct; 64(20):7562-9. PubMed ID: 15492283
[TBL] [Abstract][Full Text] [Related]
11. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X
Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial induced and self-monitored intrinsic apoptosis by antitumor theranostic prodrug: in vivo imaging and precise cancer treatment.
Kumar R; Han J; Lim HJ; Ren WX; Lim JY; Kim JH; Kim JS
J Am Chem Soc; 2014 Dec; 136(51):17836-43. PubMed ID: 25402959
[TBL] [Abstract][Full Text] [Related]
13. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.
Yao CC; Tu YR; Jiang J; Ye SF; Du HX; Zhang Y
Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic effect and mechanism of sulfate polysaccharide of algae on lung cancer].
Zhai ZG; Jiang HD; Qin XM; Wang C
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Feb; 27(2):97-100. PubMed ID: 14990183
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic study of IR-780 dye as a potential tumor targeting and drug delivery agent.
Zhang E; Luo S; Tan X; Shi C
Biomaterials; 2014 Jan; 35(2):771-8. PubMed ID: 24148240
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria targeting and near-infrared fluorescence imaging of a novel heptamethine cyanine anticancer agent.
Ning J; Huang B; Wei Z; Li W; Zheng H; Ma L; Xing Z; Niu H; Huang W
Mol Med Rep; 2017 Jun; 15(6):3761-3766. PubMed ID: 28440435
[TBL] [Abstract][Full Text] [Related]
17. Ocimum sanctum induces apoptosis in A549 lung cancer cells and suppresses the in vivo growth of Lewis lung carcinoma cells.
Magesh V; Lee JC; Ahn KS; Lee HJ; Lee HJ; Lee EO; Shim BS; Jung HJ; Kim JS; Kim DK; Choi SH; Ahn KS; Kim SH
Phytother Res; 2009 Oct; 23(10):1385-91. PubMed ID: 19277950
[TBL] [Abstract][Full Text] [Related]
18. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
19. Clitocine targets Mcl-1 to induce drug-resistant human cancer cell apoptosis in vitro and tumor growth inhibition in vivo.
Sun JG; Li H; Li X; Zeng X; Wu P; Fung KP; Liu FY
Apoptosis; 2014 May; 19(5):871-82. PubMed ID: 24563182
[TBL] [Abstract][Full Text] [Related]
20. Novel 2-step synthetic indole compound 1,1,3-tri(3-indolyl)cyclohexane inhibits cancer cell growth in lung cancer cells and xenograft models.
Lee CH; Yao CF; Huang SM; Ko S; Tan YH; Lee-Chen GJ; Wang YC
Cancer; 2008 Aug; 113(4):815-25. PubMed ID: 18618576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
